Aron M. Knickerbocker

2017

In 2017, Aron M. Knickerbocker earned a total compensation of $7.1M as President and Chief Executive Officer at Five Prime Therapeutics, a 45% increase compared to previous year.

Compensation breakdown

Bonus$107,500
Non-Equity Incentive Plan$190,860
Option Awards$5,586,258
Salary$433,750
Stock Awards$809,859
Other$6,000
Total$7,134,227

Knickerbocker received $5.6M in option awards, accounting for 78% of the total pay in 2017.

Knickerbocker also received $107.5K in bonus, $190.9K in non-equity incentive plan, $433.8K in salary, $809.9K in stock awards and $6K in other compensation.

Rankings

In 2017, Aron M. Knickerbocker's compensation ranked 1,130th out of 14,666 executives tracked by ExecPay. In other words, Knickerbocker earned more than 92.3% of executives.

ClassificationRankingPercentile
All
1,130
out of 14,666
92nd
Division
Manufacturing
378
out of 5,772
94th
Major group
Chemicals And Allied Products
100
out of 2,075
95th
Industry group
Drugs
67
out of 1,731
96th
Industry
Pharmaceutical Preparations
54
out of 1,333
96th
Source: SEC filing on March 30, 2018.

Knickerbocker's colleagues

We found four more compensation records of executives who worked with Aron M. Knickerbocker at Five Prime Therapeutics in 2017.

2017

Lewis Williams

Five Prime Therapeutics

Founder

2017

Francis Sarena

Five Prime Therapeutics

Secretary

2017

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2017

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

In-depth

You may also like